Increased SPHK2 Transcription of Human Colon Cancer Cells in Serum-Depleted Culture: The Involvement of CREB Transcription Factor

Journal of Cellular Biochemistry

Volumn 116, Issue 10, 2015, Pages 2227-2238

  Mizutani, Naoki ^a   Omori, Yukari ^a   Tanaka, Koji ^a   Ito, Hiromi ^a   Takagi, Akira ^a   Kojima, Tetsuhito ^a   Nakatochi, Masahiro ^a   Ogiso, Hideo ^b   Kawamoto, Yoshiyuki ^c   Nakamura, Mitsuhiro ^d   Suzuki, Motoshi ^e   Kyogashima, Mamoru ^f   Tamiya Koizumi, Keiko ^a   Nozawa, Yoshinori ^f   Murate, Takashi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c CHUBU UNIVERSITY   (Japan)

^d GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^e NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

^f Tokai Women's Junior College   (Japan)

Author keywords

CREB TRANSCRIPTION FACTOR; HUMAN COLON CANCER CELL LINES; JNK ACTIVATION; SERUM DEPRIVATION; SPHK2; TRANSCRIPTIONAL REGULATION

Indexed keywords

COMPLEMENTARY DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; SPHINGOSINE KINASE 2; TRANSCRIPTION FACTOR; CREB1 PROTEIN, HUMAN; PHOSPHOTRANSFERASE; PROTEIN BINDING; SERUM-FREE MEDIUM; SPHINGOSINE KINASE; SPHINGOSINE KINASE 2, HUMAN;

ARTICLE; BINDING SITE; CANCER CELL LINE; CELL CULTURE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CELL DIFFERENTIATION; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; METABOLISM; PATHOLOGY; SERUM-FREE MEDIUM;

CELL DIFFERENTIATION; CELL PROLIFERATION; COLONIC NEOPLASMS; CULTURE MEDIA, SERUM-FREE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN BINDING; RNA, MESSENGER;

EID: 84939194170     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25173     Document Type: Article

References (47)

1. Alemany R, van Koppen CJ, Danneberg K, Ter Braak M, Meyer Zu Heringdorf D,. 2007. Regulation and functional roles of sphingosine kinases. Naunyn Schmiedebergs Arch Pharmacol 374: 413-428.
2. Antoon JW, Meacham WD, Bratton MR, Slaughter EM, Rhodes LV, Ashe HB, Wiese TE, Burow ME, Beckman BS,. 2011. Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer. J Mol Endocrinol 46: 205-216.
3. Arias J, Alberts AS, Brindle P, Claret FX, Smeal T, Karin M, Feramisco J, Montminy M,. 1994. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370: 226-229.
4. Barlow CA, Kitiphongspattana K, Siddiqui N, Roe MW, Mossman BT, Lounsbury KM,. 2008. Protein kinase A-mediated CREB phosphorylation is an oxidant-induced survival pathway in alveolar type II cells. Apoptosis 13: 681-692.
5. Barr RK, Bogoyevitch MA,. 2001. The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). Int J Biochem Cell Biol 33: 1047-1063.
6. Beljanski V, Knaak C, Zhuang Y, Smith CD,. 2011. Combined anticancer effects of sphingosine kinase inhibitors and sorafenib. Invest New Drugs 29: 1132-1142.
7. Canhoto AJ, Chestukhin A, Litovchick L, DeCaprio JA,. 2000. Phosphorylation of the retinoblastoma-related protein p130 in growth-arrested cells. Oncogene 19: 5116-5122.
8. Cavigelli M, Dolfi F, Claret FX, Karin M,. 1995. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J 14: 5957-5964.
9. Dai L, Qi Y, Chen J, Kaczorowski D, Di W, Wang W, Xia P,. 2014. Sphingosine kinase (SphK) 1 and SphK2 play equivalent roles in mediating insulin's mitogenic action. Mol Endocrinol 28: 197-207.
10. Deak M, Clifton AD, Lucocq LM, Alessi DR,. 1998. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 17: 4426-4441.
11. Ding G, Sonoda H, Yu H, Kajimoto T, Goparaju SK, Jahangeer S, Okada T, Nakamura S,. 2007. Protein kinase D-mediated phosphorylation and nuclear export of sphingosine kinase 2. J Biol Chem 282: 27493-27502.
12. Engel N, Lisec J, Piechulla B, Nebe B,. 2012. Metabolic profiling reveals sphingosine-1-phosphate kinase 2 and lyase as key targets of (phyto-) estrogen action in the breast cancer cell line MCF-7 and not in MCF-12A. PLoS ONE 7: e47833.
13. French KJ, Zhuang Y, Maines LW, Gao P, Wang W, Beljanski V, Upson JJ, Green CL, Keller SN, Smith CD,. 2010. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J Pharmacol Exp Ther 333: 129-139.
14. Gao P, Smith CD,. 2011. Ablation of sphingosine kinase-2 inhibits tumor cell proliferation and migration. Mol Cancer Res 9: 1509-1519.
15. Gestaut MM, Antoon JW, Burow ME, Beckman BS,. 2014. Inhibition of sphingosine kinase-2 ablates androgen resistant prostate cancer proliferation and survival. Pharmacol Rep 66: 174-178.
16. Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, Singh SK, Luo C, Marmorstein R, Kordula T, Milstien S, Spiegel S,. 2009. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325: 1254-1257.
17. Hait NC, Sarkar S, Le Stunff H, Mikami A, Maceyka M, Milstien S, Spiegel S,. 2005. Role of sphingosine kinase 2 in cell migration toward epidermal growth factor. J Biol Chem 280: 29462-29469.
18. Hannun YA, Obeid LM,. 2008. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9: 139-150.
19. Igarashi N, Okada T, Hayashi S, Fujita T, Jahangeer S, Nakamura S,. 2003. Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J Biol Chem 278: 46832-46839.
20. Kwok RP, Lundblad JR, Chrivia JC, Richards JP, Bachinger HP, Brennan RG, Roberts SG, Green MR, Goodman RH,. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370: 223-226.
21. Lee B, Cao R, Choi YS, Cho HY, Rhee AD, Hah CK, Hoyt KR, Obrietan K,. 2009. The CREB/CRE transcriptional pathway: Protection against oxidative stress-mediated neuronal cell death. J Neurochem 108: 1251-1265.
22. Lee SH, Jung YS, Chung JY, Oh AY, Lee SJ, Choi DH, Jang SM, Jang KS, Paik SS, Ha NC, Park BJ,. 2011. Novel tumor suppressive function of Smad4 in serum starvation-induced cell death through PAK1-PUMA pathway. Cell Death Dis 2: e235.
23. Leicht M, Briest W, Holzl A, Zimmer HG,. 2001. Serum depletion induces cell loss of rat cardiac fibroblasts and increased expression of extracellular matrix proteins in surviving cells. Cardiovasc Res 52: 429-437.
24. Li Z, Zhang H, Chen Y, Fan L, Fang J,. 2012. Forkhead transcription factor FOXO3a protein activates nuclear factor kappaB through B-cell lymphoma/leukemia 10 (BCL10) protein and promotes tumor cell survival in serum deprivation. J Biol Chem 287: 17737-17745.
25. Maceyka M, Milstien S, Spiegel S,. 2009. Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling. J Lipid Res 50 Suppl S272-S276.
26. Maceyka M, Sankala H, Hait NC, Le Stunff H, Liu H, Toman R, Collier C, Zhang M, Satin LS, Merrill AH, Jr., Milstien S, Spiegel S,. 2005. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 280: 37118-37129.
27. Mastrandrea LD, Sessanna SM, Laychock SG,. 2005. Sphingosine kinase activity and sphingosine-1 phosphate production in rat pancreatic islets and INS-1 cells: response to cytokines. Diabetes 54: 1429-1436.
28. Mayr B, Montminy M,. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609.
29. Mizutani N, Kobayashi M, Sobue S, Ichihara M, Ito H, Tanaka K, Iwaki S, Fujii S, Ito Y, Tamiya-Koizumi K, Takagi A, Kojima T, Naoe T, Suzuki M, Nakamura M, Banno Y, Nozawa Y, Murate T,. 2013. Sphingosine kinase 1 expression is downregulated during differentiation of Friend cells due to decreased c-MYB. Biochim Biophys Acta 1833: 1006-1016.
30. Nemoto S, Nakamura M, Osawa Y, Kono S, Itoh Y, Okano Y, Murate T, Hara A, Ueda H, Nozawa Y, Banno Y,. 2009. Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation. J Biol Chem 284: 10422-10432.
31. Okada T, Ding G, Sonoda H, Kajimoto T, Haga Y, Khosrowbeygi A, Gao S, Miwa N, Jahangeer S, Nakamura S,. 2005. Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis. J Biol Chem 280: 36318-36325.
32. Okuyama E, Suzuki A, Murata M, Ando Y, Kato I, Takagi Y, Takagi A, Murate T, Saito H, Kojima T,. 2013. Molecular mechanisms of syndecan-4 upregulation by TNF-alpha in the endothelium-like EAhy926 cells. J Biochem 154: 41-50.
33. Olivera A, Urtz N, Mizugishi K, Yamashita Y, Gilfillan AM, Furumoto Y, Gu H, Proia RL, Baumruker T, Rivera J,. 2006. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J Biol Chem 281: 2515-2525.
34. Pfeilschifter W, Czech-Zechmeister B, Sujak M, Mirceska A, Koch A, Rami A, Steinmetz H, Foerch C, Huwiler A, Pfeilschifter J,. 2011. Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia. Biochem Biophys Res Commun 413: 212-217.
35. Piret JP, Lecocq C, Toffoli S, Ninane N, Raes M, Michiels C,. 2004. Hypoxia and CoCl2 protect HepG2 cells against serum deprivation- and t-BHP-induced apoptosis: a possible anti-apoptotic role for HIF-1. Exp Cell Res 295: 340-349.
36. Pitson SM,. 2011. Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem Sci 36: 97-107.
37. Pyne NJ, Pyne S,. 2010. Sphingosine 1-phosphate and cancer. Nat Rev Cancer 10: 489-503.
38. Rosen H, Gonzalez-Cabrera PJ, Sanna MG, Brown S,. 2009. Sphingosine 1-phosphate receptor signaling. Annu Rev Biochem 78: 743-768.
39. Sankala HM, Hait NC, Paugh SW, Shida D, Lepine S, Elmore LW, Dent P, Milstien S, Spiegel S,. 2007. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. Cancer Res 67: 10466-10474.
40. Sivasubramanian M, Kanagaraj N, Dheen ST, Tay SS,. 2015. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP-treated MN9D cells in vitro. Neuroscience 290C: 636-648.
41. Sobue S, Murakami M, Banno Y, Ito H, Kimura A, Gao S, Furuhata A, Takagi A, Kojima T, Suzuki M, Nozawa Y, Murate T,. 2008. V-Src oncogene product increases sphingosine kinase 1 expression through mRNA stabilization: Alteration of AU-rich element-binding proteins. Oncogene 27: 6023-6033.
42. Thomas R, Kim MH,. 2008. HIF-1 alpha: A key survival factor for serum-deprived prostate cancer cells. Prostate 68: 1405-1415.
43. van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P,. 1995. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J 14: 1798-1811.
44. Wang J, Gu Z, Ni P, Qiao Y, Chen C, Liu X, Lin J, Chen N, Fan Q,. 2011. NF-kappaB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loop. Nucleic Acids Res 39: 6440-6455.
45. Weigert A, Schiffmann S, Sekar D, Ley S, Menrad H, Werno C, Grosch S, Geisslinger G, Brune B,. 2009. Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype. Int J Cancer 125: 2114-2121.
46. Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH, Biggs JR, Kraft AS, Yang VW,. 2000. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 275: 18391-18398.
47. Zhao Y, Qiu F, Xu S, Yu L, Fu G,. 2011. Thymosin beta4 activates integrin-linked kinase and decreases endothelial progenitor cells apoptosis under serum deprivation. J Cell Physiol 226: 2798-2806.